Thermo Fisher opens its second site in a week, this time closer to its Massachusetts headquarters
24 Aug 2022
Gene Therapy
Manufacturing giant Thermo Fisher is continuing its recent streak of major openings, and this one is much closer to its headquarters in Waltham, MA.
The company announced on Wednesday that it has opened a new viral vector manufacturing plant in Plainville, MA, about 48 miles from Boston. The 300,000-square-foot site, which cost the company $180 million, will add approximately 300 jobs to the area for the development, testing and manufacturing of viral vectors, which are vital for the development of gene therapies.
When announced in 2020, the site was expected to double the company’s commercial viral vector capacity.
Preview
Source: Endpts
Marc Casper
“Plainville is an impressive addition to our pharma services network as we continue to invest and innovate cell and gene therapy services, products and workflows. We are enabling our customers to speed their scientific discoveries in cell and gene therapy while also supporting their manufacturing needs, whether they are early in the development process or ready to transition to clinical or commercial scale,” said Thermo Fisher CEO Marc Casper in a statement.
In an email to Endpoints News, Thermo Fisher said that the new site helps to expand the company’s clinical and commercial viral vector capacity to six sites in the US and Europe. It also supports the cell and gene therapy value chain, from early development and clinical scale-up to commercial manufacturing. Additionally, the company told Endpoints that employees started work at the site a few months ago and that it is in the early stages of production.
Thermo Fisher, as part of global expansion plans, outlines new single-use site in Nashville
According to the company, the new Plainville facility is part of a wider investment strategy in cell and gene therapies. However, it is separate from the $650 million investment Thermo Fisher announced last year — which included several single-use sites across the US, UK and China.
That investment has seen Thermo Fisher open a new site in Utah and New York state in recent months, as well as a $105 million biologics site outside of Nashville earlier this week.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.